1/ 🚨 ⚡ New paper 💊 Reduction of aversive learning rates by angiotensin II antagonist losartan: a randomised clinical trial 🧑🏽 Judith Appel, Corinna Klinge, @LorikaShk @michaelbrowni19 @KatjaWiech and Andrea Reinecke Now in Biological Psychiatry: doi.org/10.1016/j.biop…
3
7
23
4K
7
2/ TLDR: Blockade of angiotensin receptors (using losartan) reduces aversive learning rates relative to placebo, suggesting a potential utility of the drug in prevention of development of PTSD/anxiety disorders.